Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ

Abstract

Background and study aims Few studies have evaluated detection of pancreatic carcinoma in situ (PCIS). We evaluated findings of endoscopic ultrasound (EUS) and pathological features of PCIS.

Patients and methods We histopathologically studied 16 patients with PCIS following EUS. Diagnostic features evaluated retrospectively included stricture of the main pancreatic duct (MPD) on EUS, presence or absence of hypoechoic areas surrounding the MPD stricture on EUS, the noncancerous part (pancreas of background) on EUS and histopathology, and histological findings adjacent to the area of PCIS.

Results On EUS, stricture of the MPD was found in 15 patients (93.8 %). Hypoechoic areas surrounding the MPD stricture were observed in 9 patients (56.3 %), including three (18.8 %) with a 10- to 11-mm hypoechoic mass. EUS findings of the noncancerous part indicated chronic pancreatitis in six patients (37.5 %), pancreatic fatty infiltration in seven (43.8 %), early chronic pancreatitis in two (12.5 %), and normal pancreas in one (6.3 %). Histological findings of the noncancerous part (proximal to the MPD stricture) indicated chronic pancreatitis in 13 patients (81.3 %) and pancreatic fatty infiltration in five patients (31.3 %). Histopathologically, subepithelial inflammatory cell infiltration and fibrosis were present in all 16 patients with PCIS.

Conclusions PCIS frequently causes localized changes in inflammation and fibrosis around the pancreatic duct. PCIS often accompanies chronic pancreatitis and pancreatic fatty infiltration in the background of the pancreas. EUS offers sufficient resolution to demonstrate pancreatic changes of PCIS.

• References

• 1 Vital Statistics Japan 2013. Cancer death. Ministry of Health, Labor and Welfare; 2013 . Available at: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei13/dl/11_h7.pdf] [Accessed November 14, 2017]
• 2 Rahib L, Smith BD, Aizenberg R. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74: 2913-2921
• 3 Egawa S, Toma H, Ohigashi H. et al. Japan pancreatic cancer registry; 30th year anniversary: Japan Pancreas Society. Pancreas 2012; 41: 985-992
• 4 Yamaguchi K, Okusaka T, Shimizu K. et al. EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis. Jpn J Clin Oncol 2014; 44: 883-888
• 5 Hanada K, Okazaki A, Hirano N. et al. See comment in PubMed Commons below “Diagnostic strategies for early pancreatic cancer”. J Gastroenterol 2015; 50: 147-154
• 6 Hruban RH, Takaori K, Klimstra DS. et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28: 977-987
• 7 Basturk O, Hong SM, Wood LD. et al. A revised classification system and recommendations from the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol 2015; 12: 1730-1741
• 8 Catalano MF, Sahai A, Levy M. et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc 2009; 69: 1251-1261
• 9 The Research Committee of the Intractable Pancreatic Diseases supported by the Ministry of Health, Labor and Welfare of Japan, Japan Pancreas Society, The Japanese Society of Gastroenterology. Japanese clinical diagnostic criteria for chronic pancreatitis 2009. Suizo; 2009 24. 645-646 [Available at: https://www.jstage.jst.go.jp/article/suizo/24/6/24_6_645/_pdf/-char/en]
• 10 Whitcomb DC, Frulloni L, Garg P. et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology 2016; 16: 218-224
• 11 Sommers SC, Murphy SA, Warren S. Pancreatic duct hyperplasia and cancer. Gastroenterology 1954; 27: 629-640
• 12 Hruban RH, Goggins M, Parsons J. et al. Progression model for pancreatic cancer. Clin Cancer Res 2000; 6: 2969-2972
• 13 Apte MV, Park S, Phillips PA. et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004; 29: 179-187
• 14 Yachida S, Jones S, Bozic I. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-1117
• 15 Del Chiaro M, Verbeke CS, Kartalis N. et al. Short-term results of a magnetic resonance imaging-based Swedish screening program for individuals at risk for pancreatic cancer. JAMA Surg 2015; 6: 512-518
• 16 Harinck F, Konings IC, Kluijt I. et al. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut 2016; 9: 1505-1513
• 17 Canto MI, Hruban RH, Fishman EK. et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012; 4: 796-804
• 18 Verna EC, Hwang C, Stevens PD. et al. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res 2010; 20: 5028-5037
• 19 Yasuda I, Iwashita T, Doi S. et al. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc 2011; 23: 22-25
• 20 Kamata K, Kitano M, Kudo M. et al. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy 2014; 1: 22-29
• 21 Hanada K, Shinzato M, Okazaki A. et al. The role and actual practice of EUS in the early diagnosis of pancreatic cancer – Can PCIS be diagnosed?. J Tanto to sui 2014; 35: 677-683
• 22 Iiboshi T, Hanada K, Fukuda T. et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of PCIS. Pancreas 2012; 41: 523-529
• 23 Raimondi S, Lowenfels AB, Morselli-Labate AM. et al. Pancreatic cancer in chronic pancreatitis; etiology, incidence, and early detection. Best Prac Res Clin Gastroenterol 2010; 24: 349-358
• 24 Tomita Y, Azuma K, Nonaka Y. et al. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Pancreas 2014; 43: 1032-1041
• 25 Rebours V, Gaujoux S, d'Assignies G. et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanIN). Clin Cancer Res 2015; 21: 3522-3528
• 26 Yamaguchi K, Kanemitsu S, Hatori T. et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011; 40: 571-580
• 27 Maguchi H, Tanno S, Mizuno N. et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas 2011; 40: 364-370
• 28 Okazaki A, Hanada K, Ikemoto J. et al. The possibility of pancreatic cancer onset based on long-term observation of early-stage chronic pancreatitis. J Tanto to sui 2016; 37: 399-407